Serrapeptase is an enzyme derived from silkworm intestines first used in Europe and Asia. Its use became more common in the United States in the mid-1990s. The enzyme is thought to help ease inflammation and pain when taken several times a day. Serrapeptase works by targeting "dead" material in the body--including things like scar tissue and fibroids (benign tumors that usually appear in a women's uterus). The fibroid cells expand until the tumor becomes a rubbery mass. Serrapeptase attacks those masses by breaking down the cells that cause the fibroids to grow.
Purchase serrapeptase from an herbal store or online dealer. Look for a product that has 5 mg or 10 mg pills.
Take 10 mg total each day, splitting the doses into 5 mg in the morning and 5 mg at night.
Take the serrapeptase on an empty stomach with 8 oz. of water and do not eat for at least 90 minutes after taking the pills.
Observe your body on the 10 mg dosage. Be aware of any negative reactions, such as nausea or bruising. If you experience any bad side effects, stop taking the enzyme.
Increase your dosage after at least one week on 10 mg of serrapeptase. Increase the daily dosage amount to 20 mg, taking 10 mg each morning and night. Continue to take the pills on an empty stomach with 8 oz. of water.
Consult your physician about how long to continue taking serrapeptase. The answer varies by an individual's health and the nature of the fibroids.
Always check with your physician before starting an alternative treatment such as serrapeptase.
Do not take serrapeptase if you are pregnant or breastfeeding, taking blood thinners or have stomach ulcers.
Serrapeptase supplements are not regulated by the Food and Drug Administration, so exercise caution before taking the enzyme.
Tallulah Philange has worked as a journalist since 2003. Her work has appeared in the "Princeton (N.J.) Packet," "Destinations" magazine and in higher education publications. She also has edited and produced online content for those publications. Philange holds a Bachelor of Arts in print journalism from American University and a Master of Arts in communication, culture and technology from Georgetown University.